Company Overview

Bioxalis Medica Inc. specializes in the development and application of innovative drug delivery technologies for both oral and topical products. The company’s technology is based on the utilization of a hydrogel-based formulation to control sustained-release delivery properties of a drug or cosmeceutical product. Bioxalis Medica Inc. is a biopharmaceutical company engaged in the research and development of products for use in the treatment of cancer. The Company's efforts in oncology are focused on developing products for application as direct cancer treatment agents that have the dual objectives of extending life and improving the quality of life for cancer patients worldwide. These agents ...

Bioxalis Medica Inc. specializes in the development and application of innovative drug delivery technologies for both oral and topical products. The company’s technology is based on the utilization of a hydrogel-based formulation to control sustained-release delivery properties of a drug or cosmeceutical product. Bioxalis Medica Inc. is a biopharmaceutical company engaged in the research and development of products for use in the treatment of cancer. The Company's efforts in oncology are focused on developing products for application as direct cancer treatment agents that have the dual objectives of extending life and improving the quality of life for cancer patients worldwide. These agents referred to as Tumor Vasculature Targeting agents, or TVTs, attack a tumor's network of existing and emerging blood vessels which are its main life support system. Bioxalis Medica Inc. was formerly known as Gelkem Inc. The company was founded in 1997 and is based in Quebec City, Canada. As of June 29, 2005, Bioxalis Medica inc. operates as a subsidiary of Ambrilia Biopharma, Inc.

Key Executives for Bioxalis Medica inc.

Similar Private Companies By Industry

Recent Private Companies Transactions